Allscripts (MDRX) Reports In-Line Q2 EPS

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $428 million versus the consensus estimate of $425 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• Hyperscale Data launches $300M at-the-market stock offering